(2026). Interleukin‐1α‐Mediated Activation of TNF‐α/NF‐κB Signaling Confers Resistance to Osimertinib in EGFR‐Mutant Non‐Small‐Cell Lung Cancer. Thoracic Cancer.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Interleukin‐1α‐Mediated Activation of TNF‐α/NF‐κB Signaling Confers Resistance to Osimertinib in EGFR‐Mutant Non‐Small‐Cell Lung Cancer."
Thoracic Cancer 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Interleukin‐1α‐Mediated Activation of TNF‐α/NF‐κB Signaling Confers Resistance to Osimertinib in EGFR‐Mutant Non‐Small‐Cell Lung Cancer."
Thoracic Cancer, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.